Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Chad Stasik

Thoracic Surgery (Cardiothoracic Vascular Surgery) San Antonio, TX Medical Doctor

NPI 1164511200 CMS profile 7140

4330 Medical Dr Ste 325, Ste 210, San Antonio, TX 78229

Open in the dashboard

General payments

$35,629

530 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Chad Stasik of San Antonio, TX is reported in the CMS Open Payments database as having received $35,629 across 530 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 86th percentile of Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $4,843 116
2024 General $4,136 96
2023 General $4,689 85
2022 General $3,702 67
2021 General $4,767 67
2020 General $6,322 30
2019 General $7,169 69

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Chad Stasik
  • Thoracic Surgery (Cardiothoracic Vascular Surgery) median
  • Middle half of Thoracic Surgery (Cardiothoracic Vascular Surgery)
  • National median

In program year 2025, general payments to Chad Stasik were reported at $4,843. Among 4,073 Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles paid that year, the median was $791 and the middle half received between $208 and $3,074.

Show as a table
Year Chad Stasik Thoracic Surgery (Cardiothoracic Vascular Surgery) median Middle half National median
2019 $7,169 $886 $178–$3,167 $163
2020 $6,322 $341 $108–$1,605 $114
2021 $4,767 $453 $125–$1,886 $132
2022 $3,702 $695 $180–$2,566 $149
2023 $4,689 $745 $205–$2,662 $160
2024 $4,136 $799 $214–$2,967 $164
2025 $4,843 $791 $208–$3,074 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Intuitive Surgical, Inc. $13,458 38 payments
  2. Medtronic, Inc. $6,073 218 payments
  3. Atricure, Inc. $3,882 61 payments
  4. Abbott Laboratories $3,005 42 payments
  5. Abiomed $2,943 35 payments
  6. Medtronic Vascular, Inc. $1,169 18 payments
  7. Edwards Lifesciences Corporation $951 28 payments
  8. Corcym Inc $761 6 payments
  9. Maquet Cardiovascular U.S. Sales, L.L.C. $588 10 payments
  10. Bolton Medical Inc $540 14 payments
  11. Other $2,258 60 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $21,161 503 payments
  2. Education $10,676 8 payments
  3. Travel and Lodging $3,200 16 payments
  4. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $500 1 payment
  5. Consulting Fee $57 1 payment
  6. Gift $35 1 payment
Products named General payments · program years 2019–2025
  1. Da Vinci Surgical System Surgery $11,458 36 payments
  2. COREVALVE EVOLUT R $4,636 176 payments
  3. Impella $2,217 23 payments
  4. ATRICLIP LAA EXCLUSION SYSTEM $1,792 38 payments
  5. SYNERGY ABLATION SYSTEM $1,730 30 payments
  6. Da Vinci Surgical System Surgery $1,500 1 payment
  7. ATRICURE CRYOICE CRYOABLATION SYSTEM (CRYO2) $1,437 28 payments
  8. EPIC $1,252 23 payments
  9. CoreValve Evolut $1,173 36 payments
  10. Mitra Clip system $1,159 11 payments
  11. Other $9,471 177 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 51 billing codes

Paid by Medicare

$190,286

Medicare's payments for the services billed

Medicare patients

241

Average age 77

Services billed

599

90 women, 151 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 75%
Heart failure 61%
Diabetes 53%
Atrial fibrillation 52%
Chronic kidney disease 46%
Arthritis 46%
COPD 33%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

1 product · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
CLEVIPREX
  • CHIESI USA, INC. $17
$17 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

530 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Thoracic Surgery (Cardiothoracic Vascular Surgery) in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record